A Study of TAVO101 in Atopic Dermatitis Patients

Status:
Recruiting

Trial end date:
2025-01-31

Target enrollment:

Participant gender:

This is a Phase 2 pilot study to examine the preliminary efficacy, safety and PK of TAVO101 in adult patients with severe AD.

Phase 2

Tavotek Biotherapeutics